San Mateo, CA, United States of America

Byung Gyu Kim

Average Co-Inventor Count = 14.0

ph-index = 3

Forward Citations = 13(Granted Patents)

Forward Citations (Not Self Cited) = 10(Sep 21, 2024)

Location History:

  • San Mateo, CA (US) (2012 - 2014)
  • Daejeon, KR (2018 - 2022)


Years Active: 2012-2022

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: The Innovative Journey of Byung Gyu Kim

Introduction: Byung Gyu Kim, a skilled inventor based in San Mateo, California, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of six patents, his work primarily focuses on innovative compounds aimed at combating metabolic diseases and autoimmune disorders.

Latest Patents: Among his latest patents, Byung Gyu Kim developed a biaryl derivative that acts as a GPR120 agonist. This patent describes compounds with a specific chemical formula, including methods for producing these compounds, and explores their pharmaceutical applications in preventing or treating inflammation and various metabolic diseases, such as diabetes and obesity.

Another notable patent involves ROR modulators, detailing compounds that can modulate ROR activity within cells. The patent specifies the composition of these compounds, including their pharmaceutically acceptable salts and hydrates. These compounds are proposed as potential treatments for autoimmune and inflammatory disorders, showcasing the breadth of Kim's innovative efforts in the pharmaceutical industry.

Career Highlights: Throughout his career, Byung Gyu Kim has been associated with leading organizations, including the Exelixis Patent Company LLC and Exelixis, Inc. His experience at these firms has allowed him to develop groundbreaking solutions that address critical health challenges.

Collaborations: Over the years, Byung Gyu Kim has collaborated with esteemed colleagues such as Grace Mann and Jeff Z Chen. Their joint efforts have fostered an environment of creativity and innovation, leading to significant advancements in their respective fields.

Conclusion: Byung Gyu Kim's contributions to pharmaceutical inventiveness are notable, with a focused approach towards developing treatments for pressing health issues. His extensive patent portfolio and collaborative endeavors reflect his commitment to innovation and excellence in the industry. As he continues to forge new paths in research and development, the impact of his work will undoubtedly resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…